Schmitt, Thomas M http://orcid.org/0000-0002-0736-4195
Aggen, David H
Ishida-Tsubota, Kumiko
Ochsenreither, Sebastian
Kranz, David M
Greenberg, Philip D
Article History
Received: 13 June 2017
Accepted: 13 October 2017
First Online: 6 November 2017
Competing interests
: P.D.G. is a co-founder of Juno therapeutics, which is developing T-cell-based immunotherapies including TCR gene therapy. P.D.G. and T.M.S. are co-inventors on a patent application covering the technology described here.